-
- Posts: 83
- Joined: Sat Sep 26, 2009 9:54 am
We have an unusual case where we are quantifying a certain analyte by a non native RPC method, ie. our component of interest is unfortunately very sensitive and the RPC methods completely dissociates it to 2 subunits that appear as 2 distinct peaks, one having a sharp symmetric profile easy to integrate. So we constructed a cal. curve using a standard, that also shows same behaviour, and use the sharp peak for concentration assignment of the cal. curve levels, and accordingly, we only integrate this peak for our unknown samples for quantification. We have gained trust in our method by comparing the results to that of a native validated size exclusion HPLC method and found them very comparable.
As we are forced to use RPC method at certain stages of the production for its better separation of impurities than SE-HPLC, we were asked to validate it. The method passes linearity, precicion and accuracy, but the question, is it acceptable to validate a method that breaks down the main analyte? is there any literature to discuss such specific issues, as ICH guidelines are very generalized?
Thank you